Skip to main content

Advertisement

SpringerLink
Log in

Metastasectomy for limited metastases from soft tissue sarcoma

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

The development of metastatic soft tissue sarcoma (American Joint Committee on Cancer stage IV) is associated with a poor prognosis. Surgical resection of isolated solitary or multiple metastases is the only curative treatment; all other forms of treatment are considered palliative. As with all surgical procedures, patient selection is important to maximize the clinical benefit of metastasectomy and to minimize the risk for treatment-related morbidity. Over the past decade, nonresectional ablative approaches have been developed to manage visceral metastatic disease. These ablative procedures include cryosurgery, radiofrequency tumor ablation, and alcohol injection. All such procedures are considered investigational; outcome should be compared to that achievable with traditional surgical metastasectomy. The optimal sequence of treatments and role for perioperative (combined with metastasectomy) chemotherapy are unknown. Given the potential curative nature of metastasectomy, all patients with metastatic soft tissue sarcoma should be evaluated for the possibility of surgical resection. Patients with good performance status who have radiographically resectable disease should be considered for metastasectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Billingsley KG, Burt ME, Jara E, et al.: Pulmonary metastases from soft tissue sarcoma: analysis of patterns of disease and postmetastasis survival. Ann Surg 1999, 229:602–612. An excellent analysis of post-metastasis outcome.

    Article  PubMed  CAS  Google Scholar 

  2. van Geel AN, Pastorino U, Jauch KW, et al.: Surgical treatment of lung metastases: the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer 1996, 77:675–682. A retrospective study of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group.

    Article  PubMed  Google Scholar 

  3. Casson AG, Putnam JB Jr, Natarajan G, et al.: Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer 1992, 69:662–668.

    Article  PubMed  CAS  Google Scholar 

  4. Gadd MA, Casper ES, Woodruff JM, et al.: Development and treatment of pulmonary metastases in adult patients with extremity soft-tissue sarcoma. Ann Surg 1993, 218:705–712.

    Article  PubMed  CAS  Google Scholar 

  5. Rizzoni WE, Pass HI, Wesley MN, et al.: Resection of recurrent pulmonary metastases in patients with soft-tissue sarcomas. Arch Surg 1986, 121:1248–1252.

    Article  PubMed  CAS  Google Scholar 

  6. Pogrebniak HW, Roth JA, Steinberg SM, et al.: Reoperative pulmonary resection in patients with metastatic soft tissue sarcoma. Ann Thorac Surg 1991, 52:197–203.

    Article  PubMed  CAS  Google Scholar 

  7. Porter GA, Cantor SB, Ahmad SA, et al.: Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer 2002, 94:197–204. The objective of this study was to determine the yield and cost effectiveness of routine versus selective chest CT scanning for the staging of patients with T2 STS and to identify any subgroups for whom a more selective approach to chest CT scanning could be considered.

    Article  PubMed  Google Scholar 

  8. Lewis JJ, Brennan MF: Soft tissue sarcomas. Curr Probl Surg 1996, 33:817–872.

    PubMed  CAS  Google Scholar 

  9. Putnam JB Jr, Roth JA: Surgical treatment for pulmonary metastases from sarcoma. Hematol Oncol Clin North Am 1995, 9:869–887. An excellent review of the role of pulmonary metastasectomy.

    PubMed  Google Scholar 

  10. Foster JH: Survival after liver resection for secondary tumors. Am J Surg 1978, 135:389–394.

    Article  PubMed  CAS  Google Scholar 

  11. Harrison LE, Brennan MF, Newman E, et al.: Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 1997, 121:625–632.

    Article  PubMed  CAS  Google Scholar 

  12. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, et al.: Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg 1998, 187:487–493.

    Article  PubMed  CAS  Google Scholar 

  13. Hemming AW, Sielaff TD, Gallinger S, et al.: Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl 2000, 6:97–101.

    PubMed  CAS  Google Scholar 

  14. Kohno H, Nagasue N, Araki S, et al.: Ten-year survival after synchronous resection of liver metastasis from intestinal leiomyosarcoma. Cancer 1981, 47:1421–1423.

    Article  PubMed  CAS  Google Scholar 

  15. Shimizu J, Sasaki M, Nakamura Y, et al.: Simultaneous lung and liver resection for primary pulmonary leiomyosarcoma. Respiration 1997, 64:179–181.

    Article  PubMed  CAS  Google Scholar 

  16. Karakousis CP, Blumenson LE, Canavese G, et al.: Surgery for disseminated abdominal sarcoma. Am J Surg 1992, 163:560–564.

    Article  PubMed  CAS  Google Scholar 

  17. Hafner GH, Rao U, Karakousis C: Liver metastases from soft tissue sarcoma. J Surg Oncol 1995, 58:12–16.

    Article  PubMed  CAS  Google Scholar 

  18. Jaques DP, Coit DG, Casper ES, et al.: Hepatic metastases from soft-tissue sarcoma. Ann Surg 1995, 221:392–397.

    Article  PubMed  CAS  Google Scholar 

  19. Chen H, Pruitt A, Nicol TL, et al.: Complete hepatic resection of metastases from leiomyosarcoma prolongs survival. J Gastrointest Surg 1998, 2:151–155.

    Article  PubMed  CAS  Google Scholar 

  20. Ogose A, Morita T, Hotta T, et al.: Intra-abdominal metastases in musculoskeletal sarcomas. J Orthop Sci 2000, 5:463–469.

    Article  PubMed  CAS  Google Scholar 

  21. Lang H, Nubbaum KT, Kaudel P, et al.: Hepatic metastases from leiomyosarcoma: a single-center experience with 34 liver resections during a 15-year period. Ann Surg 2000, 231:500–505.

    Article  PubMed  CAS  Google Scholar 

  22. DeMatteo RP, Shah A, Fong Y, et al.: Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 2001, 234:540–547. An updated report from the Memorial Sloan-Kettering Cancer Center that clearly demonstrates that some patients derive long-term clinical benefit from hepatic resection.

    Article  PubMed  CAS  Google Scholar 

  23. Blanke CD, von Mehren M, Joensuu H, et al.: Evaluation of the safety and efficacy of an oral molecularlytargeted therapy, STI571, in patients (Pts) with unresectable or metastatic gastrointestinal stromal tumors (GISTs) expressing C-KIT (CD117) [abstract]. Proc Am Soc Clin Oncol 2001, 20:1a.

    Google Scholar 

  24. van Oosterom AT, Judson IR, Verweij J, et al.: STI571, an active drug in metastatic gastrointestinal stromal tumors (GISTs), and EORTC phase I study [abstract]. Proc Am Soc Clin Oncol 2001, 1:1a.

    Google Scholar 

  25. von Mehren M, Blanke CD, Joensuu H, et al.: High incidence of durable responses induced by imatinib mesylate (Gleevec) in patients with unresectable and metastatic gastrointestinal stromal tumors (GISTs) [abstract]. Proc Am Soc Clin Oncol 2002, 21:403a.

    Google Scholar 

  26. Curley SA: Radiofrequency ablation of malignant liver tumors. Oncologist 2001, 6:14–23. A state-of-the-art review of radiofrequency ablation.

    Article  PubMed  CAS  Google Scholar 

  27. Parikh AA, Curley SA, Fornage BD, et al.: Radiofrequency ablation of hepatic metastases. Semin Oncol 2002, 29:168–182.

    Article  PubMed  Google Scholar 

  28. Curley SA: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Ann Surg 1999, 230:1–8.

    Article  PubMed  CAS  Google Scholar 

  29. Solbiati L, Goldberg SN, Ierace T, et al.: Radio-frequency ablation of hepatic metastases: postprocedural assessment with a U.S. microbubble contrast agent-early experience. Radiology 1999, 211:643–649.

    PubMed  CAS  Google Scholar 

  30. Sullivan KL: Hepatic artery chemoembolization. Semin Oncol 2002, 29:145–151.

    Article  PubMed  Google Scholar 

  31. Mavligit GM, Zukwiski AA, Ellis LM, et al.: Gastrointestinal leiomyosarcoma metastatic to the liver: durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine. Cancer 1995, 75:2083–2088.

    Article  PubMed  CAS  Google Scholar 

  32. Rajan DK, Soulen MC, Clark TW, et al.: Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization. J Vasc Interv Radiol 2001, 12:187–193.

    Article  PubMed  CAS  Google Scholar 

  33. Alexander HR Jr, Bartlett DL, Libutti SK: Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver. Oncologist 2000, 5:416–424.

    Article  PubMed  CAS  Google Scholar 

  34. Lindner P, Fjalling M, Hafstrom L, et al.: Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan. Eur J Surg Oncol 1999, 25:179–185.

    Article  PubMed  CAS  Google Scholar 

  35. Giese NA, Raykov Z, DeMartino L, et al.: Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice. Cancer Gene Ther 2002, 9:432–442.

    Article  PubMed  CAS  Google Scholar 

  36. Fuji N, Fujiwara H, Ueda Y, et al.: Augmentation of local antitumor immunity in the liver by tumor vaccine modified to secrete murine interleukin 12. Gene Ther 1999, 6:1120–1127.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, 77030-4009, Houston, TX, USA

    Eddie K. Abdalla MD & Peter W. T. Pisters MD, FACS

Authors
  1. Eddie K. Abdalla MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter W. T. Pisters MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdalla, E.K., Pisters, P.W.T. Metastasectomy for limited metastases from soft tissue sarcoma. Curr. Treat. Options in Oncol. 3, 497–505 (2002). https://doi.org/10.1007/s11864-002-0069-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-002-0069-1

Keywords

Search

Navigation